Korro Bio Inc. (KRRO)

Precedente Chiudi:

$52.77

Aprire:

$52.17

Volume 24 ore:

37,317

Capitalizzazione di mercato:

$475.32M

Reddito:

-

Utile/perdita netta:

$-81.17M

Rapporto P/E:

-

EPS:

-

Flusso di cassa netto:

$-75.12M

1 W Prestazione:

-6.60%

1M Prestazione:

-30.13%

6M Prestazione:

+25.64%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$50.34

$52.90

Portata 52W:

$34.07

$97.91

Korro Bio Inc. Stock (KRRO) Company Profile

Nome

Korro Bio Inc.

Settore

Healthcare (1211)

Industria

Biotechnology (697)

Telefono

781-315-4600

Indirizzo

One Kendall Square, Building 600-700 Suite 6-401, Cambridge

Dipendente

95

Cinguettio

Prossima data di guadagno

2024-06-11

Ultimi documenti SEC

KRRO's Discussions on Twitter

Korro Bio Inc. Stock (KRRO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-03-28	Reiterato	H.C. Wainwright	Buy
2024-02-27	Iniziato	BMO Capital Markets	Outperform
2023-12-04	Iniziato	H.C. Wainwright	Buy
2023-11-29	Iniziato	RBC Capital Mkts	Outperform
2023-11-10	Iniziato	Piper Sandler	Overweight
2023-02-15	Downgrade	Chardan Capital Markets	Buy → Neutral
2023-02-13	Downgrade	Cowen	Outperform → Market Perform
2021-09-22	Downgrade	Goldman	Buy → Neutral
2021-01-27	Aggiornamento	JP Morgan	Neutral → Overweight
2020-12-22	Iniziato	B. Riley Securities	Buy
2020-07-14	Iniziato	Oppenheimer	Outperform
2020-05-18	Downgrade	JP Morgan	Overweight → Neutral
2019-10-28	Iniziato	Cowen	Outperform
2019-10-28	Iniziato	Goldman	Buy
2019-10-28	Iniziato	JP Morgan	Overweight

Mostra tutto

Korro Bio Inc. Borsa (KRRO) Ultime notizie

Korro Bio (NASDAQ:KRRO) Price Target Lowered to $100.00 at HC Wainwright - MarketBeat

MarketBeat

BMO bullish on Korro Bio's new CMO appointment, maintains $120 stock PT - Investing.com

Investing.com

Korro Bio (NASDAQ:KRRO) Receives Outperform Rating from BMO Capital Markets - MarketBeat

MarketBeat

Korro Bio advances RNA editing candidate KRRO-110 By Investing.com - Investing.com

Investing.com

Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer

GlobeNewswire Inc.

Korro Announces $70 Million Private Placement - citybiz

citybiz

Korro Bio Inc. Azioni (KRRO) Dati Finanziari

Korro Bio Inc. (KRRO) Reddito netto 2024

Korro Bio Inc. (KRRO) Flusso di cassa 2024

Korro Bio Inc. (KRRO) Utile per azione 2024